Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.03 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.05 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |